SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, AYX


(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Dec. 25, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Daseke, Inc. (NASDAQ: DSKE)'s sale to TFI International Inc. for $8.30 in cash per common share. If you are a Daseke shareholder, click here to learn more about your rights and options .

Karuna Therapeutics, Inc. (NASDAQ: KRTX)'s sale to Bristol Myers Squibb for $330.00 per share in cash. If you are a Karuna shareholder, click here to learn more about your rights and options .

Alteryx, Inc. (NYSE: AYX)'s sale to Clearlake Capital Group, L.P. and Insight Partners for $48.25 per share in cash for each share of Alteryx Class A or Class B common stock. If you are an Alteryx shareholder, click here to learn more about your rights and options .

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email ... or ... .

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
...
...


MENAFN25122023004107003653ID1107655460


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.